 administration folic acid epileptic adults phenytoin-induced gingival hyperplasia double-blind placebo-controlled parallel study Twenty institutionalized epileptic adults phenytoin-induced gingival hyperplasia groups daily mg capsule folic acid weeks randomized double-blind parallel study Serum folate phenytoin levels baseline completion study Twelve areas gingiva patient intervals weeks respect indexes hyperplasia gingival health plaque index significant differences treatment groups indexes time poststudy serum folate levels times baseline levels active drug group unchanged placebo group Phenytoin blood levels therapeutic window micrograms/ml therapeutic window groups reported seizure activity single daily oral mg capsule folic acid efficacy sole therapeutic agent reduction phenytoin-induced gingival hyperplasia